FDA Inspection 1219421 — Kaken Pharmaceutical Co., Ltd.
The FDA completed an inspection of Kaken Pharmaceutical Co., Ltd. on September 1, 2023 in Fujieda. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fujieda (Japan)